Display options
Share it on

Drug Saf Case Rep. 2015 Dec;2(1):4. doi: 10.1007/s40800-015-0006-4.

Yellow Feet in a Patient with Breast and Thyroid Carcinoma, Due to Oral Intake of Turmeric.

Drug safety - case reports

Liran Horev, Yuval Ramot, Laurent Klapholz

Affiliations

  1. Department of Dermatology, Hadassah-Hebrew University Medical Center, PO Box 12000, 9112001, Jerusalem, Israel. [email protected].
  2. Department of Dermatology, Hadassah-Hebrew University Medical Center, PO Box 12000, 9112001, Jerusalem, Israel.

PMID: 27747716 PMCID: PMC5005595 DOI: 10.1007/s40800-015-0006-4

Abstract

Yellow discoloration of the skin may be caused by several etiologies, including jaundice, hypervitaminosis, drug reaction or chemical exposure. Herein we describe a 68-year-old woman with a history of breast and thyroid carcinoma, presenting with a yellow discoloration of her soles, after ingestion of one capsule a day of turmeric root extract (Bluebonnet Turmeric Root, 500 mg, Vcap), taken for its anti-cancer properties, for 4 months. After drug cessation, the yellow hue disappeared completely. A Naranjo assessment score of 5 was obtained, indicating a probable relationship between the patient's symptom and her use of the drug. Curcumin, a mixture of diferuloymethane derivatives known as curcuminoids, is a yellow pigment present in the spice turmeric. Topical application of curcumin to the human skin is joined by orange-yellow discoloration. To the best of our knowledge, yellow skin discoloration after oral intake of turmeric is not mentioned in the medical literature.

References

  1. J Am Acad Dermatol. 2007 Dec;57(6):1051-8 - PubMed
  2. South Med J. 2007 Mar;100(3):328-30 - PubMed
  3. J Am Acad Dermatol. 2012 Nov;67(5):e201-2 - PubMed
  4. J Drugs Dermatol. 2013 Oct;12(10):1131-7 - PubMed
  5. Gene. 2014 Aug 10;546(2):226-32 - PubMed
  6. Cancer Res Treat. 2014 Jan;46(1):2-18 - PubMed
  7. Int J Dermatol. 2003 Mar;42(3):178-81 - PubMed
  8. Drug Metab Dispos. 1999 Apr;27(4):486-94 - PubMed
  9. Cancer Chemother Pharmacol. 2013 Jun;71(6):1521-30 - PubMed

Publication Types